These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12436441)

  • 1. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
    Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
    Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
    Chan KL; Guan XY; Ng IO
    Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis.
    Abou-Elella A; Gramlich T; Fritsch C; Gansler T
    Mod Pathol; 1996 Feb; 9(2):95-8. PubMed ID: 8657726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of c-myc and cyclin D1 genes in primary and metastatic carcinomas of the liver.
    Takahashi Y; Kawate S; Watanabe M; Fukushima J; Mori S; Fukusato T
    Pathol Int; 2007 Jul; 57(7):437-42. PubMed ID: 17587243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual fluorescence in situ hybridization in detection of HER-2 oncogene amplification in primary hepatocellular carcinoma.
    Huang TJ; Huang BJ; Liang QW; Huang CW; Fang Y
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):62-8. PubMed ID: 14969840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
    Wu B; Wang M; You W; Yang S
    Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amplification of RIT1 in hepatocellular carcinoma and its clinical significance].
    Li JT; Liu W; Kuang ZH; Chen HK; Li DJ; Feng QS; Liu QC; Hu B
    Ai Zheng; 2003 Jul; 22(7):695-9. PubMed ID: 12866958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent amplification of JUN in hepatocellular carcinoma.
    Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
    Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.
    Qin LX; Tang ZY; Sham JS; Ma ZC; Ye SL; Zhou XD; Wu ZQ; Trent JM; Guan XY
    Cancer Res; 1999 Nov; 59(22):5662-5. PubMed ID: 10582679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.
    Inagaki Y; Yasui K; Endo M; Nakajima T; Zen K; Tsuji K; Minami M; Tanaka S; Taniwaki M; Itoh Y; Arii S; Okanoue T
    Cancer Genet Cytogenet; 2008 Jan; 180(1):30-6. PubMed ID: 18068530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between clinical characteristics, survival and genetic alterations in patients with hepatocellular carcinoma from Saudi Arabia.
    Al-Qahtani A; Al-Hazzani T; Al-hussain T; Al-Ghamdi A; Al-Mana H; Al-Arifi S; Al-Ahdal M; Aly M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):269-77. PubMed ID: 21156243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of c-myc oncogene amplification in primary hepatocellular carcinoma by interphase fluorescence in situ hybridization].
    Fang Y; Huang B; Liang Q; Li H; Huang C
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):180-2. PubMed ID: 11866973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of c-myc gene amplification, MTS1/p16 gene alternation, and HBV infection in human hepatocellular carcinoma].
    Zhang J; Wang K; Cong S; Qiu F; Wang X; Wang P
    Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):294-6. PubMed ID: 11676877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.
    Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C
    Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
    Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
    J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative detection of HER-2 oncogene amplification in primary hepatocellular carcinoma using dual FISH technique and its clinical significance].
    Huang BJ; Huang TJ; Liang QW; Huang CW; Fang Y
    Yi Chuan Xue Bao; 2001; 28(9):793-800. PubMed ID: 11582736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.
    Bubendorf L; Kononen J; Koivisto P; Schraml P; Moch H; Gasser TC; Willi N; Mihatsch MJ; Sauter G; Kallioniemi OP
    Cancer Res; 1999 Feb; 59(4):803-6. PubMed ID: 10029066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
    Shen HW; Wu YL; Peng SY
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.